I 
110TH CONGRESS 
2D SESSION 
H. R. 6568 
To direct the Secretary of Health and Human Services to encourage research 
and carry out an educational campaign with respect to pulmonary hyper-
tension, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 22, 2008 
Mr. BRADY of Texas (for himself and Mrs. CAPPS) introduced the following 
bill; which was referred to the Committee on Energy and Commerce, and 
in addition to the Committee on Ways and Means, for a period to be sub-
sequently determined by the Speaker, in each case for consideration of 
such provisions as fall within the jurisdiction of the committee concerned 
A BILL 
To direct the Secretary of Health and Human Services to 
encourage research and carry out an educational cam-
paign with respect to pulmonary hypertension, and for 
other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Tom Lantos Pul-
monary Hypertension Research and Education Act of 
2008’’. 
VerDate Aug 31 2005 
06:30 Jul 23, 2008
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6568.IH
H6568
erowe on PROD1PC71 with BILLS
SEC. 2. TABLE OF CONTENTS. 
The table of contents for this Act is as follows: 
Sec. 1. Short title. 
Sec. 2. Table of contents. 
TITLE I—RESEARCH ON PULMONARY HYPERTENSION 
Sec. 101. Expansion and intensification of activities. 
TITLE II—INCREASING AWARENESS OF PULMONARY 
HYPERTENSION 
Sec. 201. Promoting public awareness. 
Sec. 202. Promoting awareness among health care professionals. 
TITLE III—GOVERNMENT ACCOUNTABILITY OFFICE STUDY 
Sec. 301. Study on Medicare and Medicaid coverage standards for pulmonary 
hypertension therapies. 
TITLE I—RESEARCH ON 
PULMONARY HYPERTENSION 
SEC. 101. EXPANSION AND INTENSIFICATION OF ACTIVI-
TIES. 
(a) SENSE OF CONGRESS.—It is the sense of the Con-
gress that— 
(1) the Secretary of Health and Human Serv-
ices (in this Act referred to as the ‘‘Secretary’’), act-
ing through the Director of the National Institutes 
of Health and the Director of the National Heart, 
Lung, and Blood Institute (in this title referred to 
as the ‘‘Institute’’), should continue aggressive work 
on pulmonary hypertension; 
(2) as part of such work, the Director of the In-
stitute should continue research to expand the un-
VerDate Aug 31 2005 
06:30 Jul 23, 2008
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6568.IH
H6568
erowe on PROD1PC71 with BILLS
derstanding of the causes of, and to find a cure for, 
pulmonary hypertension; and 
(3) activities under paragraph (1) may include 
conducting and supporting— 
(A) basic research concerning the etiology 
and causes of pulmonary hypertension; 
(B) basic research on the relationship be-
tween scleroderma, sickle cell anemia (and other 
conditions identified by the Director of the In-
stitute that can lead to a secondary diagnosis of 
pulmonary hypertension), and pulmonary hy-
pertension; 
(C) clinical research for the development 
and evaluation of new treatments for pul-
monary hypertension, including the establish-
ment of a ‘‘Pulmonary Hypertension Clinical 
Research Network’’; 
(D) support for the training of new clini-
cians and investigators with expertise in the 
pulmonary hypertension; and 
(E) information and education programs 
for the general public. 
(b) BIENNIAL REPORTS.—As part of the biennial re-
port made under section 403 of the Public Health Service 
Act (42 U.S.C. 283), the Secretary shall include informa-
VerDate Aug 31 2005 
06:30 Jul 23, 2008
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H6568.IH
H6568
erowe on PROD1PC71 with BILLS
tion on the status of pulmonary hypertension research at 
the National Institutes of Health. 
TITLE II—INCREASING AWARE-
NESS OF PULMONARY HYPER-
TENSION 
SEC. 201. PROMOTING PUBLIC AWARENESS. 
(a) IN GENERAL.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall carry out an educational campaign to increase 
public awareness of pulmonary hypertension. Print, video, 
and Web-based materials distributed under this program 
may include— 
(1) basic information on pulmonary hyper-
tension and its symptoms; and 
(2) information on— 
(A) the incidence and prevalence of pul-
monary hypertension; 
(B) diseases and conditions that can lead 
to pulmonary hypertension as a secondary diag-
nosis; 
(C) the importance of early diagnosis; and 
(D) the availability, as medically appro-
priate, of a range of treatment options and pul-
monary hypertension. 
VerDate Aug 31 2005 
06:30 Jul 23, 2008
Jkt 069200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H6568.IH
H6568
erowe on PROD1PC71 with BILLS